Simmerafil
From Wikipedia, the free encyclopedia
 | |
| Clinical data | |
|---|---|
| Other names | TPN171 |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C24H35N5O3 |
| Molar mass | 441.576 g·mol−1 |
Simmerafil[1] (TPN171H) is a selective PDE5 inhibitor[2] in development for the treatment of erectile dysfunction[3] and pulmonary hypertension.[4]